Search
Imlifidase
go.drugbank.com/drugs/DB15258ApprovedInvestigational[A225836] As a result, highly sensitized individuals experience marked delays on transplant lists due to the challenges associated with procuring an HLA compatible donor graft.
Maftivimab
go.drugbank.com/drugs/DB15899ApprovedInvestigational[A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming an increasingly attractive therapeutic method to combat infectious diseases due to its rapid development, low toxicity, and high
Allogeneic processed thymus tissue
go.drugbank.com/drugs/DB16736ApprovedAllogeneic processed thymus tissue is used for immune reconstitution in immune disorders where the patients are severely immunocompromised due to the absence of a functional thymus, such as congenital
Tizaterkib
go.drugbank.com/drugs/DB21296InvestigationalTizaterkib has a monoisotopic molecular weight of 494.2 Da.
Mizacorat
go.drugbank.com/drugs/DB21458InvestigationalMizacorat has a monoisotopic molecular weight of 494.21 Da.
Monlunabant
go.drugbank.com/drugs/DB21537InvestigationalMonlunabant has a monoisotopic molecular weight of 590.11 Da.
Odesivimab
go.drugbank.com/drugs/DB15900ApprovedInvestigational[A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming an increasingly attractive therapeutic method to combat infectious diseases due to its rapid development, low toxicity, and high
Cilomilast
go.drugbank.com/drugs/DB03849InvestigationalFollowing four clinical trials, the drug proved to be effective in treating COPD, however it has never been marketed due to a poor side effect profile.
Telratolimod
go.drugbank.com/drugs/DB19590InvestigationalTelratolimod has a monoisotopic molecular weight of 593.47 Da.
Icenticaftor
go.drugbank.com/drugs/DB21466InvestigationalIcenticaftor has a monoisotopic molecular weight of 361.09 Da.